We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
This fun and exciting game show-style CME program now comes to endocrinology and features key opinion leaders (KOLs) as contestants.
KOL Knockout™ is back for Round 2 and the competition is heating up! The reigning champ Rokshana R. Thanadar, MD, FACE, FEAA, Kaniksha Desai MD, ECNU, FACE, and Melissa Garduno Young, MD, FACE, FACP, ECNU, will tackle complex cases and provide valuable insights into their problem-solving process. Don’t miss this opportunity to witness the ultimate TED expertise showdown, hosted by Malini Gupta, MD, ECNU, FACE.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Host:
Malini Gupta, MD, ECNU, FACE, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Creative Consultant. Speaker's Bureau: IBSA and Horizon. Owner/Employee: G2Endo/Consolidated Medical Practices of Memphis.
Faculty:
Kaniksha Desai MD, ECNU, FACE, has had no financial relationships with ineligible companies.
Rokshana R. Thanadar, MD, FACE, FEAA, has no financial relationships or affiliations with ineligible companies.
Melissa Garduno Young, MD, FACE, FACP, ECNU, has no financial relationships or affiliations with ineligible companies.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
After participating in this educational activity, participants should be better able to:
This certified continuing education activity is designed for endocrinologists and endocrine care providers involved in the care of patients with thyroid eye disease.
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Horizon Therapeutics. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
KOL Knockout™ is back for Round 2 and the competition is heating up! The reigning champ Rokshana R. Thanadar, MD, FACE, FEAA, Kaniksha Desai MD, ECNU, FACE, and Melissa Garduno Young, MD, FACE, FACP, ECNU, will tackle complex cases and provide valuable insights into their problem-solving process. Don’t miss this opportunity to witness the ultimate TED expertise showdown, hosted by Malini Gupta, MD, ECNU, FACE.
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Host:
Malini Gupta, MD, ECNU, FACE, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Creative Consultant. Speaker's Bureau: IBSA and Horizon. Owner/Employee: G2Endo/Consolidated Medical Practices of Memphis.
Faculty:
Kaniksha Desai MD, ECNU, FACE, has had no financial relationships with ineligible companies.
Rokshana R. Thanadar, MD, FACE, FEAA, has no financial relationships or affiliations with ineligible companies.
Melissa Garduno Young, MD, FACE, FACP, ECNU, has no financial relationships or affiliations with ineligible companies.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
After participating in this educational activity, participants should be better able to:
This certified continuing education activity is designed for endocrinologists and endocrine care providers involved in the care of patients with thyroid eye disease.
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an unrestricted educational grant from Horizon Therapeutics.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Horizon Therapeutics. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Stay current with the best on medical education
